{
    "SPADE_UN_12126": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_12126",
            "Peptide Name": "LGL13K (De Novo Synthesis)",
            "Source": "synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GKIIKLKASLKLL",
            "Sequence Length": 13,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.31071184] Gram-positive bacteria:Staphylococcus aureus Xen36(MIC=83.3μg/ml), Staphylococcus aureus USA300(Uknow);Gram-negative bacteria:Pseudomonas aeruginosa (MIC=10.4μg/ml)",
            "Hemolytic Activity": "[Ref.31071184] LD50=560μg/ml against human blood cells",
            "Cytotoxicity": "[Ref.31071184] The cytotoxicity of L-GL13K on HEK cells is 2.1%, 3.3%, 2.4%, 1.2%24.3%, 51.7% and 73.6% at peptide concentrations of 1, 3.9, 15.6, 62.5, 250 and 1000 μg/mL, while the cytotoxicity of PMX on HEK cells (Control samples) is 1.2%, 1.2%, 6.6%, 3.6%, 39.6%, 47.1% and 68.5% at peptide concentrations of 1, 3.9, 15.6, 62.5, 250 and 1000 μg/mL.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C68H129N17O15",
            "Mass": 1424.86,
            "PI": 10.48,
            "Net Charge": 4,
            "Hydrophobicity": 0.71,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.",
            "Literature": [
                {
                    "Title": "In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K.",
                    "Pubmed ID": "31071184",
                    "Reference": "PLoS One. 2019 May 9;14(5)e0216669. doi 10.1371/journal.pone.0216669. eCollection 2019.",
                    "Author": "Gorr SU, Flory CM, Schumacher RJ",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31071184"
                }
            ],
            "Frequent Amino Acids": "KLI",
            "Absent Amino Acids": "CDEFHMNOPQRTUVWY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 6,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_05731",
                    "Similarity": 1.0,
                    "Sequence": "FLGGLLASLLGKI"
                },
                {
                    "SPADE_ID": "SPADE_UN_12127",
                    "Similarity": 1.0,
                    "Sequence": "GKIIKLKASLKLL"
                },
                {
                    "SPADE_ID": "SPADE_UN_12408",
                    "Similarity": 1.0,
                    "Sequence": "GIIPIISIIGKII"
                }
            ]
        }
    }
}